Recent evidence has implicated endothelin-1 (ET-1) as an autocrine inhibitor of inner medullary collecting duct (IMCD) sodium and water transport. The regulators of IMCD ET-1 production are, however, largely unknown. Because of the unique hypertonic environment of the IMCD, the effect of varying extracellular tonicity on IMCD ET-1 production was evaluated. Increasing media osmolality from 300 to 450 mosmol with NaCl or mannitol but not urea caused a marked dose-and timedependent reduction in ET-1 release by and ET-1 mRNA in cultured rat IMCD cells. In contrast, increasing osmolality had no effect on ET-1 production by rat endothelial or mesangial cells. To see if ET-1 varies in a similar manner in vivo, ET-1 production was assessed in volume expanded (lower medullary tonicity) or volume depleted (high medullary tonicity) rats. Urinary ET-1 excretion and inner medulla ET-1 mRNA were significantly reduced in volume depleted as compared to volume expanded animals. These results indicate that extracellular sodium concentration inhibits ET-1 production specifically in IMCD cells. We speculate that extracellular sodium concentration, via regulation of ET-1 production, provides a link between volume status and IMCD sodium and water reabsorption. (J. Clin. Invest. 1993. 91:1235-1240
Introduction
Endothelin-1 (ET-1 )' was originally characterized as a 21-amino acid peptide produced by endothelial cells (1) . Subsequent studies have demonstrated that ET-1 is found in the greatest concentration in the inner medulla of the kidney (2) . ET-1 in the renal inner medulla, however, has a fundamentally different function than does ET-1 derived from the endotheHum. Initial characterization of ET-1 revealed that it caused vasoconstriction ( 1) and stimulated aldosterone (3) and vasopressin (4) secretion, factors leading to elevated blood pressure and salt or water retention. In contrast, ET-1 causes an increase in renal salt and water excretion when infused in doses that have little renal vasoconstrictive effect (5) . These latter actions of ET-1 are most likely mediated by the inner medullary collecting duct (IMCD). First, most endothelin receptors in the nephron are located here (6) . Second, numerous studies have demonstrated that ET-1 potently inhibits vasopressin-stimulated cAMP accumulation and water transport in IMCD (7, 8) . Furthermore, ET-1 reduces Na/K ATPase activity in the IMCD (9) . The reasons why ET-1 should have diametrically opposed physiologic effects in the vasculature as compared to the IMCD are unknown, but may reflect the localized nature of this peptide's actions. Endothelial cell-derived ET-1 is thought to primarily constrict adjacent vascular smooth muscle. Similarly, the ET-1 that modulates IMCD function is most likely derived from local sites. Since the IMCD is the predominant nephron site of ET-1 synthesis (10), it is likely that the IMCD itself is responsible, at least in large part, for producing the ET-1 that regulates its own function. Indeed, recent studies have demonstrated that ET-1 is an autocrine factor in the IMCD ( 11). Consequently, a novel autocrine system exists in the inner medulla whereby ET-1, produced in large amounts by the IMCD, binds to high density, high affinity receptors ( 12) on the IMCD with resultant inhibition of sodium and water reabsorption.
Characterization of the factor(s) controlling ET-1 production by the IMCD would provide important insights into the function ofthis system; however, little is currently known. We have previously shown that several agents that increase ET-1 production by endothelial cells have no effect on ET-1 production by IMCD cells ( 13) . This suggests that ET-1 production by IMCD cells might be regulated by factors unique to this cell type. The environment of the renal inner medulla is unique in that interstitial osmolality varies between 300 and 1,200 mosmol/ kg H20. These high osmolalities are responsible for maintaining a gradient for fluid absorption across the IMCD; increases in inner medullary osmolality occur under conditions favoring sodium and water retention (e.g., dehydration), while decreases in inner medullary osmolality occur under conditions favoring sodium and water loss (e.g., excessive intake of salt and water). Since ET-1 can function in an autocrine manner to modify IMCD sodium and water transport, the possibility exists that one means by which osmolality might regulate IMCD function is through modulation of ET-1 production.
Since ET-1 may inhibit sodium and water reabsorption, one would predict that high osmolality in the medulla (as seen in volume depletion) would reduce ET-1 production in the IMCD, thereby enhancing sodium and water retention. Determination of effect of osmolality on ET-I release. Confluent monolayers of IMCD cells were rinsed twice with DME without phenol red containing 10mM Hepes, 5 ,gg/ ml insulin, 5 Mg/ ml transferrin and 5 ng/ ml selenium (phenol red-free DME). Selenium alone or containing various amounts of added NaCl, urea, or mannitol was added to both apical and basolateral sides of the monolayer and incubated for 1-24 h at 370C in a 5% CO2 incubator. Apical and basolateral media were combined and processed as described by Sugiura et al. ( 15) . The media was mixed with 1/1o vol of 5% BSA and 1/40 vol of 0.4% Triton X-305. The media was applied to a cartridge (Bond Elut C8 Analytichem Int., Harbor City, CA) prewashed successively with 100% acetonitrile/0. 1% trifluoroacetic acid (TFA), 100% methanol (MeOH)/0. 1% TFA, and 0.1% TFA. After applying the sample, the column was washed with 0.1% TFA and 40% MeOH/0.1% TFA and endothelin eluted with 70% MeOH/0.1% TFA/0.01% Triton X-305. The eluate was concentrated (Speed Vac; Savant, Farmingdale, NY) and suspended in RIA buffer. This procedure resulted in recovery of 82±6 (n = 5) of 128 pg and 87±5% (n = 5) of 8 pg of ET-1 standards added to I ml of incubation media.
ET-1 was measured using a kit purchased from Peninsula Laboratories, Inc. (Belmont, CA) and as previously described by this laboratory ( 10). The lower limit of sensitivity for ET-l detection was 2 pg. Intraassay variation was < 9%; interassay variation was < 15%. Competitive binding inhibition curves for ET-1 antibody showed < 5% cross-reactivity with unlabeled ET-3 and < 3% cross-reactivity with unlabeled ET-2. Reactivity with big endothelin has not been evaluated.
The insert containing the cell monolayer was placed into 0.1 N NaOH. An aliquot was mixed with Bradford reagent (Bio-Rad Laboratories, Richmond, CA) and protein concentration determined by measuring absorbance at 590 nm ( 10) . All results are expressed as pg ET-l / mg protein.
Determination ofeffect ofosmolality on ET-J mRNA. Traditional Northern analysis and RNase protection assays were not sensitive enough to detect ET-1 mRNA under all conditions studied, hence a quantitative PCR method was used as previously described ( 16) . Cultured IMCD cells previously exposed to varying osmolalities were overlaid with 4 M guanidinium thiocyanate, 25 mM sodium citrate, 1% #-mercaptoethanol, and 1% sarcosyl (pH 7.0). After homogenization, each sample was subjected to cesium chloride density gradient centrifugation. The RNA pellet was washed in 70% ethanol, chloroform extracted, and ethanol precipitated. The integrity of each RNA sample was verified by agarose/formaldehyde gel electrophoresis and quantified spectrophotometrically. 2.5 Mg oftotal RNA from each sample was reverse transcribed by incubating with 100 pmol/,ul random hexamers (Boehringer Mannheim), 4 mM MgCl2, 10 U/,i murine Moloney leukemia virus reverse transcriptase (Gibco Laboratories, Grand Island, NY), 2 U/ml RNAsin (Promega Corp., Madison, WI), 500qM deoxynucleotide triphosphates (dNTP; The Perkin-Elmer Corp., Norwalk, CT), 1 mM DTT, 50 mM KCl, 10 mM Tris-Cl, and 0.01% gelatin (final buffer pH 8.3) tor 1 h at 37°C. The reverse transcriptase was inactivated by heating for 5 min at 95°C. The resultant cDNA was amplified by PCR. Each sample was measured for ET-l and #-actin cDNA in separate tubes using specific primers. The upstream and downstream primers for ET-1 were GCCAAGCAGACAAAGAAC-TCCGAG and GCTCTGTAGTCAATGTGCTCGGTT, respectively. These yielded a single 247-bp fragment. The sequence for the 247-bp fragment was analyzed by Margaret Robinson in Dr. Ray White's laboratory at the University of Utah using cycle sequencing with fluoresceinated primer ends. Analysis of the sequence revealed that it was identical to position 371-618 in rat ET-I cDNA ( 17 ) . PCR ofrat genomic DNA yielded a 1,300-bp product, indicating that these primers spanned an intron. The upstream and downstream primers for ,B-actin were TGGAGAAGAGCTATGAGCTGCCTG and GTGCCACCA-GACAGCACTGTGTTG, respectively, which yielded a 201-bp cDNA fragment. PCR Instruments, Norwalk, CT). PCR using ET-l primers was carried out for 30 cycles under identical conditions. ET-1 and fl-actin primers were never combined in the same tube. 20 /il of the final PCR reaction was electrophoresed on an 8% acrylamide (20:1 acrylamide/bis-acrylamide) gel containing 1 ,tg/ml ethidium bromide. The bands corresponding to the cDNA product were excised, mixed with scintillation cocktail, and cpm determined on a beta counter (Beckman Instruments, Fullerton, CA).
ET-I and O-actin cDNA obtained from PCR of reverse transcribed RNA were used to generate standard curves. The cDNA was amplified by PCR, the resultant amplified product divided into small fractions that were, in turn, reamplified. After removal of primers (Magic PCR Prep; Promega Corp.), the purity of the final product was confirmed by electrophoresis. At the end of the purification, the amount of standard cDNA was quantitated spectrophotometrically. Standard curves for f-actin or ET-l were made by simultaneously amplifying sample cDNA and, in separate tubes, standard cDNA (10-1-l0-7 ng/tube).
Every PCR amplification included a standard curve. All PCR consisted of simultaneous amplification (in separate tubes) of cDNA for ET-l and 3-actin. All results are expressed as ag ET-1 cDNA/pg 3-actin cDNA to control for the amount of RNA initially reverse transcribed.
The accuracy of this quantitative PCR technique has been previously described ( 16) . In brief, three separate reverse transcriptions of the same RNA sample, followed by PCR of the resultant cDNA (using the same ET-l and B-actin standard curves), yielded only a 5% and a 3% variability in measured ET-I and B-actin cDNA, respectively; the ratio of ET-l to B-actin cDNA varied by 4%. In the second control, the reproducibility of quantitation of cDNA was evaluated. Three separate PCR amplifications, each using independently made standard curves, were performed on the same sample of cDNA. The calculated amount of ET-1 and B-actin cDNA varied by 15% and 11.5%, respectively, while the ratio ofET-I to B-actin cDNA varied by 9%. Standard curves using 0.1-100 pg of f-actin cDNA (which encompasses all sample values) gave correlation coefficients invariably > 0.99. Similarly, standard curves using 0.1-100 fg of ET-l cDNA (which encompasses all sample values) gave correlation coefficients invariably > 0.98.
In vivo studies. Male Sprague-Dawley rats weighing 175-200 g were volume expanded (3 d ofdrinking 0.9% NaCl) or depleted ( 1 d ofwater deprivation). A 24-h urine sample was collected under oil on the day before death and urinary volume, urine sodium concentration and urine osmolality measured by the Clinical Chemistry laboratory at the University of Utah. Urinary ET-I concentration was measured as described above. Animals were then sacrificed by ether inhalation, serum was collected for determination of ET-1 concentration, and the renal cortex and papilla were excised and snap frozen. Frozen tissue was placed into 4 M guanidinium thiocyanate, 25 mM sodium citrate, and 1% 3-mercaptoethanol and immediately homogenized. RNA was purified and ET-I and f-actin mRNA quantitated as described above.
Statistics. All data were compared by analysis of variance. Results are expressed as mean±SEM. P values < 0.05 were taken as significant.
Materials. All chemicals and reagents were obtained from Sigma Immunochemicals, unless otherwise stated.
Results
Cell culture. To examine the regulation ofIMCD ET-1 production, it was necessary to develop a purified population of into the bathing media. (Fig. 1 A) . This effect of hypertonic NaCI on ET-1 release was largely reversible: ET-1 release increased from 27±6% of control (after 6 h in 450 mosmol/ liter media) to 82±2% of control ( 12 h after return to normal media, n = 3 each group). Raising media osmolality to 450 mosmol/ liter with NaCl resulted in a similar time-course of reduction of ET-l mRNA levels in IMCD cells (Fig. 1 B) The reduction in ET-1 production may have been caused by acute changes in osmolality, perhaps as part of the cell's early volume regulatory response. To assess this possibility, IMCD cells were grown from the time of initial plating until confluence (-72-96 h) in media at a tonicity of 300 or 450 mosmol/liter (made hypertonic with NaCl). Confluent cultures grown in 450 mosmol/liter released only 34.1±8.9% of the ET-1 released by cells grown in 300 mosmol/liter (control = 258±92 pg ET-l /,ug protein per 6 h; n = 6 each group, P < 0.001 ). These results indicate, therefore, that the reduction in ET-1 production caused by hypertonic NaCl persists for several days and is not caused by factors associated with acutely changing extracellular tonicity.
To determine if hypertonic inhibition of ET-1 production is a generalized property of cells producing the peptide, rat mesangial and endothelial cells were exposed to elevated media NaCl concentrations. Increasing media NaCl to give final osmolalities of 350, 400, and 450 mosmol/liter for 6 h resulted in a marked dose-dependent reduction of IMCD ET-1 release; however, it had no effect on ET-1 release by mesangial or endothelial cells in culture (Fig. 2) . Hence, hyperosmolality-induced inhibition ofET-I production is not a general characteristic of cells synthesizing ET-I and suggests that IMCD ET-1 production is under unique regulation.
Sodium and chloride are the major solutes in the inner medulla that increase tonicity ( 18 ) . Urea is also found in high concentrations in the inner medulla, however, because of its ability to rapidly permeate cell membranes, urea does not contribute significantly to interstitial tonicity and resultant changes in cell volume ( 18) . To determine how hypertonic NaCl reduces IMCD ET-1 production, media osmolality was increased with either NaCl, urea, or mannitol (which, like NaCl, does not enter the cell). Increasing media osmolality with either mannitol or NaCl caused a similar dose-dependent reduction in ET-1 release (Fig. 3) . In contrast, increasing media osmolality with urea had a much smaller effect on ET-1 production (Fig. 3) . These data suggest that the reduction in ET-1 release by IMCD cells is caused by factors associated with cell shrinkage rather than the osmolality of the surrounding fluid.
In vivo studies. As discussed above, hypertonic inhibition of ET-1 production could provide a mechanism by which volume status could regulate IMCD sodium and water excretion.
According to this prediction, volume depletion, which leads to a rise in inner medulla sodium concentration, should reduce IMCD ET-1 production. Conversely, volume expansion, which reduces inner medulla sodium concentration, should increase IMCD ET-1 production. To test this hypothesis, rats were either volume depleted (deprived of drinking water for 1 d) or volume expanded (given 0.9% NaCl to drink for 3 d). As expected ( 18) , urine osmolality and urine sodium concentration were markedly elevated in the dehydrated, as compared to the volume expanded, group (Table I ). The elevation in urine sodium concentration accounted for approximately one quarter ofthe rise in urine osmolality; the rest ofthe difference was likely caused by urea ( 18) . Despite a tendency for serum ET-1 levels to be higher in the volume-depleted animals, urinary ET-1 excretion was much lower in this group (Table I) . Since urinary ET-1 excretion reflects renal tubule production of ET-l ( 19) , these data suggest that volume depletion is associated with reduced nephron ET-1 production. 1 d without water) . A 24-h urine sample was collected on the day before death and urinary volume (V), urine sodium concentration (UNa), urine osmolality (Uosm), sodium excretion (UNaV), and ET-1 excretion were measured. n = 6 each group; * P < 0.001 vs dehydration. * P < 0.05 vs. dehydration.
dulla of salt-loaded as compared to dehydrated rats (Fig. 4) . Since osmolality does not appear to affect endothelial cell ET-1 production, and since the IMCD is the only other major component of the inner medulla known to make ET-I (10), these data suggest that the decrease in inner medulla ET-I mRNA in dehydration reflects lower IMCD mRNA levels.
Discussion
These studies demonstrate that increases in extracellular tonicity result in decreased ET-I production by cultured IMCD cells. Since sodium is the predominant impermeant solute in the inner medulla, it is reasonable to assume that if this system is operative in vivo, then interstitial sodium concentration regulates ET-1 production by the IMCD. The finding that inner medullary ET-i mRNA and urinary ET-1 excretion are reduced in the setting of high medullary tonicity supports the hypothesis that extracellular tonicity regulates ET-1 production by the IMCD. Why an autocrine pathway for regulation of salt and water transport exists in the IMCD is unknown. Taken together, these in vivo and in vitro studies provide an important clue as to the purpose of this system. It has been recognized that renal medullary blood flow rises during conditions associated with sodium and water loading and falls during volume depletion (20) . Elevated medullary blood flow would act to "wash out" solutes, thereby lowering medullary tonicity, while decrements in medullary blood flow would act in the opposite direction to raise medullary tonicity (20 Osmotic regulation of ET-1 synthesis and actions in the inner medulla has been examined in preliminary studies. Hyperosmolality has been demonstrated to reduce ET-I binding to interstitial cells in the inner medulla (23), providing another mechanism by which increased tonicity could reduce ET-I actions. In contrast, in another preliminary study, it was noted that increasing media osmolality to 600 mosmol/liter with NaCl, mannitol, or urea resulted in stimulation of ET-1 immunostaining of IMCD cells in culture (24) . It is not certain, however, that immunostaining accurately reflects ET-I production. Furthermore, since immunostaining was the only parameter evaluated, the significance of these preliminary observations is unclear. Another study has evaluated the renal response to an intravenous infusion of antiendothelin antiserum (25) . These investigators found that animals on a low sodium but not a high sodium diet increased sodium excretion when given antiendothelin antiserum. Since IMCD ET-I production would be expected to be relatively low on a low sodium diet, these results can not be explained by alterations in IMCD ET-I actions. On the contrary, plasma renin activity, which was markedly elevated in animals on a low sodium diet, was reduced by ET-I antiserum. This could easily result in a reduction in plasma aldosterone and reduced distal nephron sodium transport. These results, therefore, underscore the differences between the endocrine and circulatory effects of ET-I and its actions in the IMCD. The challenge remains to design studies that can clearly delineate the separate function of these ET-I systems.
The reason why hypertonicity reduces ET-I release by IMCD cells, but not by endothelial or mesangial cells, is unknown. Clearly, factors must exist in the IMCD that allow this cell type to respond in a unique way to changes in environmental tonicity. Several possibilities exist as to the nature of these hypertonicity-responsive factors. First, a number of mechanisms have been identified by which tonicity might regulate gene transcription, including alterations in DNA supercoiling (26) and intracellular potassium concentration (27) . Hypertonicity may also modify mRNA translation by stabilizing untranslated RNA secondary structure (28) . These systems have, however, only been clearly identified in bacteria (26, 27) or in cells transfected with simian virus 40-based plasmids (28 
